Q3 2025 · 13F-HR
Trustees of Columbia University in the City of New Yorkholdings as filed
Filed 2025-11-14 · accession 0000904454-25-000601
$655.3M
Reported value
8
Positions
2025-09-30
Period end
The Brief · Trustees of Columbia University in the City of New York · Q3 2025
AI · grounded in 13F
Trustees of Columbia University in the City of New York established a new position in SPY valued at $653.3M. The fund also initiated new stakes in SRZN for $617,579 and TNYA for $472,761. Other new additions include QTTB, RAPT, and VOR.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $653.3M | 99.7% | 980,596 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $617,579 | 0.09% | 47,930 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $472,761 | 0.07% | 291,828 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $265,128 | 0.04% | 133,903 | Common | SOLE |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $236,546 | 0.04% | 9,172 | Common | SOLE |
| 929033207 | VOR | VOR BIOPHARMA INC | $223,868 | 0.03% | 4,595 | Common | SOLE |
| 98422T100 | XLO | XILIO THERAPEUTICS INC | $210,442 | 0.03% | 249,635 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $517 | 0.00% | 33,333 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.